For the Inventor, By the Inventor

Enter assignee name

Senhwa Biosciences, Inc.

USPTO Granted Patents = 11

EPO Patents = 7

Trademarks = 1

Forward Citations = 31

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

John Soong (4 out of 5 patents)

David M Ryckman (4 out of 11 patents)

Fabrice Pierre (4 out of 20 patents)

4. Mustapha Haddach (3 out of 34 patents)

5. Joe Anh Tran (2 out of 12 patents)

6. Suchitra Ravula (2 out of 12 patents)

7. Nicholas Brian Raffaele (2 out of 12 patents)

8. Hshiou-ting Liu (2 out of 8 patents)

9. Collin F Regan (2 out of 2 patents)

10. Michael Schwaebe (2 out of 19 patents)

11. Jeffrey Paul Whitten (2 out of 68 patents)

12. Iching G Yu (1 out of 3 patents)

13. Peter C Chua (1 out of 8 patents)

14. Levan Darjania (1 out of 2 patents)

15. Johnny Yasuo Nagasawa (1 out of 27 patents)

11 patents: Sort by Forward Citations

1. 12116363 - Combinations for immune-modulation in cancer treatment (2024-10-15),

2. 11696911 - Antiviral compounds and method for treating RNA viral infection, particularly COVID-19 (2023-07-11),

3. 11524012 - Quinolone analogs and their salts, compositions, and method for their use (2022-12-13),

4. 11229654 - Combination therapy of tetracyclic quinolone analogs for treating cancer (2022-01-25),

5. 10857156 - Combination therapy of tetracyclic quinolone analogs for treating cancer (2020-12-08),

6. 9957282 - Crystalline forms of quinolone analogs and their salts (2018-05-01),

7. 9303033 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors (2016-04-05),

8. 9062043 - Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators (2015-06-23),

9. 8853235 - Polymorphs and salts of a kinase inhibitor (2014-10-07),

10. 8853234 - Quinolone analogs and methods related thereto (2014-10-07),

11. 8575177 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors (2013-11-05),

Senhwa Biosciences, Inc. is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of cancer and other diseases. We are dedicated to improving patients' lives by discovering and developing new drugs that target unmet medical needs. With a strong pipeline of potential breakthrough therapies, we aim to make a significant impact in the field of pharmaceutical research and development. Visit our website to learn more about our mission, team, and ongoing research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#422 in Taipei

#1,273 in Taiwan

#50,231 in the World

Senhwa Biosciences, Inc.

Forward Citations = 31

16 inventors:

John Soong (4 out of 5 patents)

David M Ryckman (4 out of 11 patents)

Fabrice Pierre (4 out of 20 patents)

4. Mustapha Haddach (3 out of 34 patents)

5. Joe Anh Tran (2 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…